Robert J. Hugin

2013

In 2013, Robert J. Hugin earned a total compensation of $21M as CEO and Chairman at Celgene, a 99% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$7,236,693
Option Awards$8,729,638
Salary$1,262,500
Stock Awards$3,554,100
Other$212,854
Total$20,995,785

Hugin received $8.7M in option awards, accounting for 42% of the total pay in 2013.

Hugin also received $7.2M in non-equity incentive plan, $1.3M in salary, $3.6M in stock awards and $212.9K in other compensation.

Rankings

In 2013, Robert J. Hugin's compensation ranked 78th out of 12,286 executives tracked by ExecPay. In other words, Hugin earned more than 99.4% of executives.

ClassificationRankingPercentile
All
78
out of 12,286
99th
Division
Manufacturing
20
out of 4,612
100th
Major group
Chemicals And Allied Products
5
out of 1,466
100th
Industry group
Drugs
4
out of 1,160
100th
Industry
Pharmaceutical Preparations
4
out of 890
100th
Source: SEC filing on April 28, 2016.

Hugin's colleagues

We found four more compensation records of executives who worked with Robert J. Hugin at Celgene in 2013.

2013

Jacqualyn Fouse

Celgene

President Hematology and Oncology

2013

Mark Alles

Celgene

Chief Operating Officer

2013

Thomas Daniel

Celgene

Chairman

2013

Perry Karsen

Celgene

Chief Executive Officer

You may also like